Biosynex SA

€0.83As of Sun 8 Nov 2026, 12:00 UTC
EPA:ALBIOHealthcare
Country France
PE (Fwd) •••
TSR 10Y CAGR (8.46%)
Div yield —
ROE (34.68%)
Medical Devices
Beta (5Y) 0.97
PE TTM —
TSR TTM 31.33%
Mkt cap €15.30M
ROIC 14.63%
SE Grade™
Value
Quality
Moat
Consensus
Reference
€0.989
19.19%
(60.04%)
Hold 9|2|12|4|10
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.02
0.02
0.02
0.02
38.44%
27.32%
16.20%
4.14%
Revenue€M
0.626
0.619
0.641
0.667
(1.27%)
(2.84%)
3.62%
5.44%
Peers (US$17.18M)
Cap (US$)
PE
24.91M
—
21.61M
—
Capital
TTM
5Y
10Y
Leveragex
3.134
(0.063)
(0.056)
EBIT/Intx
1.354
0.144
0.149
Own earn%
(95.84)
29.83
11.45
Sh yield%
23.15
58.26
57.47
Owners
Insiders/Inst%
13.01
79.67
Short interest%
1.93
SBC / revenue%
0.37
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
18–27
$1 testx
0.0
Incr. ROIC%
1